Conduit Pharmaceuticals News

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

Dec 21 06:10

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

Dec 21 06:10

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

Dec 21 06:10

4: Statement of changes in beneficial ownership of securities-Director Fry Simon Jeremy

Dec 21 06:10

3: Initial statement of beneficial ownership of securities-Director Fry Simon Jeremy

Dec 21 06:10

8-K: Current report

Dec 21 06:05

8-K: Current report

Dec 18 06:19

424B3: Prospectus

Dec 17 06:03

424B3: Prospectus

Dec 9 19:16

EFFECT: Others

Dec 9 19:07

DEF 14A: Definitive information statements

Dec 6 21:31

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 27 06:23

S-3: Registration statement for specified transactions by certain issuers

Nov 26 06:12

8-K: Current report

Nov 26 05:57

4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

Nov 21 05:33

4: Statement of changes in beneficial ownership of securities-Officer Bligh James

Nov 21 05:33

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

Nov 21 05:33

4: Statement of changes in beneficial ownership of securities-Officer Tapolczay David

Nov 21 05:33

4: Statement of changes in beneficial ownership of securities-Director Lewis-Hall Freda C

Nov 21 05:33

8-K: Current report

Nov 20 06:01